These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 23279375)

  • 21. Thirty-day mortality in UK patients with community-onset and hospital-acquired meticillin-susceptible Staphylococcus aureus bacteraemia.
    Melzer M; Welch C
    J Hosp Infect; 2013 Jun; 84(2):143-50. PubMed ID: 23602415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bloodstream infections and clinical significance of healthcare-associated bacteremia: a multicenter surveillance study in Korean hospitals.
    Son JS; Song JH; Ko KS; Yeom JS; Ki HK; Kim SW; Chang HH; Ryu SY; Kim YS; Jung SI; Shin SY; Oh HB; Lee YS; Chung DR; Lee NY; Peck KR
    J Korean Med Sci; 2010 Jul; 25(7):992-8. PubMed ID: 20592888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presence of urinary symptoms in bacteremic urinary tract infection: a retrospective cohort study of Escherichia coli bacteremia.
    Bai AD; Bonares MJ; Thrall S; Bell CM; Morris AM
    BMC Infect Dis; 2020 Oct; 20(1):781. PubMed ID: 33081714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolated pathogens and clinical outcomes of adult bacteremia in the emergency department: a retrospective study in a tertiary Referral Center.
    Kao CH; Kuo YC; Chen CC; Chang YT; Chen YS; Wann SR; Liu YC
    J Microbiol Immunol Infect; 2011 Jun; 44(3):215-21. PubMed ID: 21524617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Revisiting the epidemiology of bloodstream infections and healthcare-associated episodes: results from a multicentre prospective cohort in Spain (PRO-BAC Study).
    Pérez-Crespo PMM; Lanz-García JF; Bravo-Ferrer J; Cantón-Bulnes ML; Sousa Domínguez A; Goikoetxea Aguirre J; Reguera-Iglesias JM; León Jiménez E; Armiñanzas Castillo C; Mantecón Vallejo MÁ; Marrodan Ciordia T; Fernández Suárez J; Boix-Palop L; Cuquet Pedragosa J; Jover Saenz A; Sevilla Blanco J; Galán-Sánchez F; Natera Kindelán C; Del Arco Jiménez A; Bahamonde-Carrasco A; Smithson Amat A; Vinuesa García D; Herrero Rodríguez C; Reche Molina IM; Pérez Camacho I; Sánchez-Porto A; Guzmán García M; Becerril Carral B; Merino de Lucas E; López-Hernández I; Rodríguez-Baño J; López-Cortés LE;
    Int J Antimicrob Agents; 2021 Jul; 58(1):106352. PubMed ID: 33961992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in Mid-Norway: a prospective observational study.
    Mehl A; Åsvold BO; Kümmel A; Lydersen S; Paulsen J; Haugan I; Solligård E; Damås JK; Harthug S; Edna TH
    BMC Infect Dis; 2017 Feb; 17(1):116. PubMed ID: 28148226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of microbiological and clinical characteristics based on SCCmec typing in patients with community-onset meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia.
    Kuo SC; Chiang MC; Lee WS; Chen LY; Wu HS; Yu KW; Fung CP; Wang FD
    Int J Antimicrob Agents; 2012 Jan; 39(1):22-6. PubMed ID: 21982834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors for nosocomial bacteraemia outcome: a prospective study in a Greek teaching hospital.
    Arvanitidou M; Katikaridou E; Douboyas J; Tsakris A
    J Hosp Infect; 2005 Nov; 61(3):219-24. PubMed ID: 16039015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary tract infections caused by community-acquired extended-spectrum β-lactamase-producing and nonproducing bacteria: a comparative study.
    Dayan N; Dabbah H; Weissman I; Aga I; Even L; Glikman D
    J Pediatr; 2013 Nov; 163(5):1417-21. PubMed ID: 23919903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.
    Freeman JT; McBride SJ; Nisbet MS; Gamble GD; Williamson DA; Taylor SL; Holland DJ
    Int J Infect Dis; 2012 May; 16(5):e371-4. PubMed ID: 22401750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unique characteristics of community-onset healthcare- associated bloodstream infections: a multi-centre prospective surveillance study of bloodstream infections in Japan.
    Takeshita N; Kawamura I; Kurai H; Araoka H; Yoneyama A; Fujita T; Ainoda Y; Hase R; Hosokawa N; Shimanuki H; Sekiya N; Ohmagari N
    J Hosp Infect; 2017 May; 96(1):29-34. PubMed ID: 28377180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mortality and associated risk factors in consecutive patients admitted to a UK NHS trust with community acquired bacteraemia.
    Hounsom L; Grayson K; Melzer M
    Postgrad Med J; 2011 Nov; 87(1033):757-62. PubMed ID: 21798969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The distinct category of healthcare associated bloodstream infections.
    Lenz R; Leal JR; Church DL; Gregson DB; Ross T; Laupland KB
    BMC Infect Dis; 2012 Apr; 12():85. PubMed ID: 22487002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Community-acquired bloodstream infections caused by Acinetobacter baumannii: A matched case-control study.
    Chen CT; Wang YC; Kuo SC; Shih FH; Chen TL; How CK; Yang YS; Lee YT
    J Microbiol Immunol Infect; 2018 Oct; 51(5):629-635. PubMed ID: 28701266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Kang CI; Song JH; Chung DR; Peck KR; Ko KS; Yeom JS; Ki HK; Son JS; Lee SS; Kim YS; Jung SI; Kim SW; Chang HH; Ryu SY; Kwon KT; Lee H; Moon C; Shin SY;
    Int J Antimicrob Agents; 2010 Sep; 36(3):284-7. PubMed ID: 20580534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes and risk factors for mortality in community-onset bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli, with a special emphasis on antimicrobial therapy.
    Kang CI; Wi YM; Ko KS; Chung DR; Peck KR; Lee NY; Song JH
    Scand J Infect Dis; 2013 Jul; 45(7):519-25. PubMed ID: 23509913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacteraemic urinary tract infections in a tertiary hospital in Japan: the epidemiology of community-acquired infections and the role of non-carbapenem therapy.
    Mawatari M; Hayakawa K; Fujiya Y; Yamamoto K; Kutsuna S; Takeshita N; Ohmagari N
    BMC Res Notes; 2017 Jul; 10(1):336. PubMed ID: 28750653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Community-acquired Pseudomonas aeruginosa urinary tract infections in children hospitalized in a tertiary center: relative frequency, risk factors, antimicrobial resistance and treatment.
    Marcus N; Ashkenazi S; Samra Z; Cohen A; Livni G
    Infection; 2008 Oct; 36(5):421-6. PubMed ID: 18795227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different clinical presentation of community-onset bacteremia among human immunodeficiency virus-infected and human immunodeficiency virus-uninfected adults in the ED.
    Lee CC; Chu FY; Ko WC; Chi CH
    Am J Emerg Med; 2014 Oct; 32(10):1241-7. PubMed ID: 25171801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bloodstream infections in adults: importance of healthcare-associated infections.
    Vallés J; Calbo E; Anoro E; Fontanals D; Xercavins M; Espejo E; Serrate G; Freixas N; Morera MA; Font B; Bella F; Segura F; Garau J
    J Infect; 2008 Jan; 56(1):27-34. PubMed ID: 18022242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.